Market closedNon-fractional
Certara/CERT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Certara
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Ticker
CERT
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Technology
Headquarters
Princeton, United States
Employees
1,365
Website
www.certara.com
Certara Metrics
BasicAdvanced
$2.5B
Market cap
-
P/E ratio
-$0.39
EPS
1.58
Beta
-
Dividend rate
Price and volume
Market cap
$2.5B
Beta
1.58
Financial strength
Current ratio
3.264
Quick ratio
3.038
Long term debt to equity
28.397
Total debt to equity
29.094
Interest coverage (TTM)
1.33%
Management effectiveness
Return on assets (TTM)
1.24%
Return on equity (TTM)
-5.74%
Valuation
Price to revenue (TTM)
6.867
Price to book
2.36
Price to tangible book (TTM)
-18.44
Price to free cash flow (TTM)
40.652
Growth
Revenue change (TTM)
4.73%
Earnings per share change (TTM)
-541.65%
3-year revenue growth (CAGR)
12.58%
3-year earnings per share growth (CAGR)
2.58%
What the Analysts think about Certara
Analyst Ratings
Majority rating from 11 analysts.
Certara Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$97M
9.77%
Net income
-$4.6M
-62.90%
Profit margin
-4.76%
-66.22%
Certara Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.12
$0.11
$0.09
$0.10
-
Expected
$0.13
$0.11
$0.11
$0.10
$0.10
Surprise
-4.55%
0.92%
-17.43%
1.01%
-
Certara News
AllArticlesVideos
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
GlobeNewsWire·2 weeks ago
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
GlobeNewsWire·3 weeks ago
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Certara stock?
Certara (CERT) has a market cap of $2.5B as of July 27, 2024.
What is the P/E ratio for Certara stock?
The price to earnings (P/E) ratio for Certara (CERT) stock is 0 as of July 27, 2024.
Does Certara stock pay dividends?
No, Certara (CERT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Certara dividend payment date?
Certara (CERT) stock does not pay dividends to its shareholders.
What is the beta indicator for Certara?
Certara (CERT) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Certara stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.